Aspen Pharmacare Holdings Ltd - ADR
APNHY
Market Cap$2.99B
Close$
$10.06
46.4% upside
Current Fair Value
46.4% upsideUndervalued by 46.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.99 Billion |
|---|---|
| Enterprise Value | $32.10 Billion |
| Dividend Yield | $0.2 (2.96326867519604%) |
| Earnings per Share | $9.91 |
| Beta | 0.44 |
| Outstanding Shares | 444,124,655 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 12.01 |
|---|---|
| PEG | -66.13 |
| Price to Sales | 0.07 |
| Price to Book Ratio | 0.04 |
| Enterprise Value to Revenue | 0.72 |
| Enterprise Value to EBIT | 3.61 |
| Enterprise Value to Net Income | 7 |
| Total Debt to Enterprise | 1.29 |
| Debt to Equity | 0.49 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Aspen Pharmacare Holdings Ltd
CEO: Stephen Saad